Protalix BioTherapeutics
PLX
#8567
Rank
โ‚ฌ0.11 B
Marketcap
1,62ย โ‚ฌ
Share price
1.81%
Change (1 day)
23.38%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ25.03 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total debt is โ‚ฌ25.03 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Protalix BioTherapeutics - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ23.77 M-23.82%
2022-12-31โ‚ฌ31.2 M5.59%
2021-12-31โ‚ฌ29.55 M-43.55%
2020-12-31โ‚ฌ52.35 M-3.73%
2019-12-31โ‚ฌ54.38 M29.71%
2018-12-31โ‚ฌ41.92 M-3.6%
2017-12-31โ‚ฌ43.49 M-37.51%
2016-12-31โ‚ฌ69.6 M5.56%
2015-12-31โ‚ฌ65.93 M19.07%
2014-12-31โ‚ฌ55.37 M14.06%
2013-12-31โ‚ฌ48.55 M
1999-12-31โ‚ฌ0.05 M6.34%
1998-12-31โ‚ฌ0.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ0.42 B 1,600.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.24 B 861.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ63.76 B 254,630.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.45 B 73,603.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel